Ricerca

Pubblicazioni IRIS

• Myxofibrosarcoma: a multi-target approach for new therapies’ development
  Anno: 2025
• Assessing Determinants of Response to PARP Inhibition in Germline ATM Mutant Melanoma
  Anno: 2025
• The Systematic Comparison of Enhancer of Zeste Homolog-2-, Bromodomain-containing Proteins-, Histone Deacetylase-, and DNA-methyltransferase 1-inhibitors in a Syngeneic Murine Model of Melanoma Reveals Differential Anti-tumoral and Immunomodulatory Activities
  Anno: 2025